Paper101128
beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin.
Fu KP and 1 other. Antimicrob Agents Chemother, 1978. Cited by 158 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin. Papers, record 101128. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/101128
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cephalosporins | Major topic |
| beta-Lactamase Inhibitors | Major topic |
| Drug Resistance, Microbial | |
| Pseudomonas aeruginosa |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,102,266 | Potent combinations of beta-lactam antibiotics using the beta-lactamase inhibition principle. | Chemotherapy | 1975 | https://conductscience.org/library/papers/1102266 | PubMed |
| 2 | 15,828,188 | Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/15828188 | PubMed |
| 3 | 413,795 | Experimental evaluation of HR756, a new cephalosporin derivative: pre-clinical study. | Infection | 1977 | https://conductscience.org/library/papers/413795 | PubMed |
| 4 | 4,561,388 | Inhibition of the -lactamases of Escherichia coli and Klebsiella aerogenes by semi-synthetic penicillins. | Biochem J | 1972 | https://conductscience.org/library/papers/4561388 | PubMed |
| 5 | 4,581,138 | The beta-lactamases of gram-negative bacteria and their possible physiological role. | Adv Microb Physiol | 1973 | https://conductscience.org/library/papers/4581138 | PubMed |
| 6 | 4,670,438 | Inhibition of beta-lactamases by beta-lactam antibiotics. | Antimicrob Agents Chemother | 1972 | https://conductscience.org/library/papers/4670438 | PubMed |
| 7 | 791,104 | In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/791104 | PubMed |
| 8 | 7,997 | Formation of beta-lactamase in Bacteroides fragilis: cell-bound and extracellular activity. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/7997 | PubMed |
| 9 | 856,025 | Cefoxitin resistance to beta-lactamase: a major factor for susceptibility of bacteroides fragilis to the antibiotic. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/856025 | PubMed |
| 10 | 879,738 | Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/879738 | PubMed |
| 11 | 931,792 | Cefuroxime - a new cephalosporin antibiotic. | J Antibiot (Tokyo) | 1976 | https://conductscience.org/library/papers/931792 | PubMed |
| 12 | 950,324 | Naturally-occurring beta-lactamase inhibitors with antibacterial activity. | J Antibiot (Tokyo) | 1976 | https://conductscience.org/library/papers/950324 | PubMed |
| 13 | 984,790 | Substrate inhibition of beta-lactamases, a method for predicting enzymatic stability of cephalosporins. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/984790 | PubMed |
Cited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 158 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31,555,856 | Antibiotic Resistance of LACTOBACILLUS Strains. | Curr Microbiol | 2019 | https://conductscience.org/library/papers/31555856 | PubMed |
| 8,461,630 | Cefotaxime desensitization. | Clin Investig | 1993 | https://conductscience.org/library/papers/8461630 | PubMed |
| 7,843,824 | The antimicrobial activity of cefotaxime: comparative multinational hospital isolate surveys covering 15 years. | Infection | 1994 | https://conductscience.org/library/papers/7843824 | PubMed |
| 7,447,404 | Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7447404 | PubMed |
| 7,325,628 | Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/7325628 | PubMed |
| 7,049,076 | Penem derivatives: beta-lactamase stability and affinity for penicillin-binding proteins in Escherichia coli. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/7049076 | PubMed |
| 6,983,862 | Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6983862 | PubMed |
| 6,981,376 | In vitro antagonism of beta-lactam antibiotics by cefoxitin. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6981376 | PubMed |
| 6,978,350 | In vitro evaluation of pyridine-2-azo-p-dimethylaniline cephalosporin, a new diagnostic chromogenic reagent, and comparison with nitrocefin, cephacetrile, and other beta-lactam compounds. | J Clin Microbiol | 1982 | https://conductscience.org/library/papers/6978350 | PubMed |
| 6,972,728 | Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6972728 | PubMed |
| 6,972,194 | Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6972194 | PubMed |
| 6,968,539 | Purification and properties of a new beta-lactamase from Pseudomonas cepacia. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6968539 | PubMed |
| 6,967,295 | Activity of beta-lactamase produced by Bacteroides fragilis against newly introduced cephalosporins. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6967295 | PubMed |
| 6,967,294 | Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6967294 | PubMed |
| 6,808,912 | Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6808912 | PubMed |
| 6,772,097 | Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compounds. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6772097 | PubMed |
| 6,609,701 | Des-, syn- and anti-oxyimino-delta 3-cephalosporins. Intrinsic reactivity and reaction with RTEM-2 serine beta-lactamase and D-alanyl-D-alanine-cleaving serine and Zn2+-containing peptidases. | Biochem J | 1984 | https://conductscience.org/library/papers/6609701 | PubMed |
| 6,454,378 | Role of the 7 alpha-methoxy and side-chain carboxyl of moxalactam in beta-lactamase stability and antibacterial activity. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6454378 | PubMed |
| 6,448,572 | Moxalactam (6059-S), a novel 1-oxa-beta-lactam with an expanded antibacterial spectrum: laboratory evaluation. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6448572 | PubMed |
| 6,446,879 | Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6446879 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/101128
GET https://conductscience.org/api/papers/v1/101128/cited_by?page=2